Documents
Briefs, oral arguments, agency decisions and the Federal Register.
5,436 results
0.14s
Federal Register · Rule · Jul 10, 2014
These comments relate to tobacco products that are not currently subject to chapter IX of the FD&C Act. … (Comment 7) One comment recommended that FDA “develop a schedule for periodically reevaluating and adjusting user fee percentage allocations” for tobacco product classes as well as manufacturers and importers
79 FR 39302Health and Human Services DepartmentFood and Drug AdministrationCrabmeat; Amendment of Common or Usual Name Regulation
Federal Register · Uncategorized Document · Jul 15, 1994
Comments Interested persons may, on or before September 13, 1994, submit to the Dockets Management Branch (address above) written comments regarding this proposal. … Two copies of any comments are to be submitted, except that individuals may submit one copy. Comments are to be identified with the docket number found in brackets in the heading of this document.
Health and Human Services DepartmentFood and Drug AdministrationFederal Register · Proposed Rule · Aug 3, 2020
Submit comments on information collection issues under the Paperwork Reduction Act of 1995 (PRA) by September 2, 2020. … Costs, Benefits, and Distributional Effects of the Proposed Rule Category Primary estimate Low estimate High estimate Units Year dollars Discount rate (%) Period
85 FR 46566Health and Human Services DepartmentFood and Drug AdministrationFederal Register · Notice · Mar 13, 2018
Section 1003(d)(2)(C) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 393(d)(2)(C)) authorizes FDA to conduct research relating to drugs and other FDA regulated products in carrying out … the provisions of the FD&C Act.
83 FR 10855Health and Human Services DepartmentFood and Drug AdministrationFederal Register · Rule · Jul 18, 2016
We have not received any new information or comments that would affect our previous determination. VII. Paperwork Reduction Act of 1995 This final rule contains no collection of information. … Section 301( ll ) of the Federal Food, Drug, and Cosmetic Act Our review of this petition was limited to section 409 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 348).
81 FR 46578Health and Human Services DepartmentFood and Drug AdministrationInternational Harmonization; Policy on Standards
Federal Register · Notice · Oct 11, 1995
The statutory mandates for safeguarding the public health in these product sectors are prescribed in several statutes, notably in the Federal Food, Drug, and Cosmetic Act; the Public Health Service Act … ; and the Fair Packaging and Labeling Act.
60 FR 53078Health and Human Services DepartmentFood and Drug AdministrationFederal Register · Notice · Aug 9, 2013
information on a variety of topics, including new product approvals, significant labeling changes, safety warnings, notices of upcoming public meetings, proposed regulatory guidances and opportunity to comment … , and other information of interest to patients and patient advocates; and • Hosting of periodic meetings, briefings, and listening sessions between patient advocates and FDA staff.
78 FR 48691Health and Human Services DepartmentFood and Drug AdministrationFood Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D3
Federal Register · Rule · Jun 29, 2005
Follow the instructions for submitting comments. • Agency Web site: http://www.fda.gov/dockets/ecomments . Follow the instructions for submitting comments on the agency Web site. … Paperwork Reduction Act of 1995 This final rule contains no collection of information.
70 FR 37255Health and Human Services DepartmentFood and Drug AdministrationAdvisory Committee; Notice of Meeting
Federal Register · Uncategorized Document · Jul 27, 1994
brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time required to make their comments … This notice is issued under section 10(a)(1) and (2) of the Federal Advisory Committee Act (5 U.S.C. app. 2), and FDA's regulations (21 CFR part 14) on advisory committees.
Health and Human Services DepartmentFood and Drug AdministrationAdvisory Committee; Notice of Meeting
Federal Register · Notice · Feb 2, 1995
brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time required to make their comments … This notice is issued under section 10(a)(1) and (2) of the Federal Advisory [[Page 6537]] Committee Act (5 U.S.C. app. 2), and FDA's regulations (21 CFR part 14) on advisory committees.
60 FR 6536Health and Human Services DepartmentFood and Drug AdministrationAdvisory Committee; Notice of Meeting
Federal Register · Notice · Nov 29, 1995
brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time required to make their comments … This notice is issued under section 10(a)(1) and (2) of the Federal Advisory Committee Act (5 U.S.C. app. 2), and FDA's regulations (21 CFR part 14) on advisory committees.
60 FR 61261Health and Human Services DepartmentFood and Drug AdministrationFederal Register · Proposed Rule · Dec 21, 1999
DATES: Submit written comments by March 22, 2000. Submit written comments on the information collection requirements by January 20, 2000. … A second reason is that by the time a FOIA request is filed and predisclosure notification is given, a significant period of time may have passed since the 510(k) was cleared by FDA.
64 FR 71347Health and Human Services DepartmentFood and Drug AdministrationFederal Register · Rule · Dec 15, 2022
We will review this copy, including the claimed confidential information, in our consideration of comments. … Under section 701(e)(1) of the FD&C Act (21 U.S.C. 371(e)(1)), any action for the amendment or repeal of any definition and standard of identity under section 401 of the FD&C Act for any dairy product
87 FR 76559Health and Human Services DepartmentFood and Drug AdministrationCurrent Good Manufacturing Practice Requirements for Combination Products
Federal Register · Proposed Rule · Sep 23, 2009
under the PHS Act and/or the act. … FDA requests comment on this issue.
74 FR 48423Health and Human Services DepartmentFood and Drug AdministrationList of Bulk Drug Substances That May Be Used in Pharmacy Compounding
Federal Register · Proposed Rule · Jan 7, 1999
DATES: Submit written comments on or before March 23, 1999. … Request for Comments Interested persons may, on or before March 23, 1999, submit to the Dockets Management Branch (address above) written comments regarding this proposal.
64 FR 996Health and Human Services DepartmentFood and Drug AdministrationFederal Register · Notice · Jul 1, 2005
FDA does not guarantee to accommodate or explain SPOC comments that are received after the 60-day cutoff. 5. … Periodic site visits with officials of the grantee organization may also occur.
70 FR 38177Health and Human Services DepartmentFood and Drug AdministrationAdvisory Committees; Notice of Meetings
Federal Register · Notice · Feb 20, 1997
emphasized, however, that the 1 hour time limit for an open public hearing represents a minimum rather than a maximum time for public participation, and an open public hearing may last for whatever longer period … This notice is issued under section 10(a)(1) and (a)(2) of the Federal Advisory Committee Act (5 U.S.C. app. 2), and FDA's regulations (21 CFR part 14) on advisory committees.
62 FR 7789Health and Human Services DepartmentFood and Drug AdministrationFederal Register · Notice · Aug 14, 2018
out the provisions of the FD&C Act. … The commenter suggests incorporating a parameter to capture this, for example, including a re-contact option to test recall and interpretation after a period of 2-4 days.
83 FR 40295Health and Human Services DepartmentFood and Drug AdministrationFederal Register · Proposed Rule · Feb 23, 1995
The agency is providing a short comment period of 75 days and plans to issue a notice of enforcement policy at a later date to state whether marketing may begin prior to the issuance of the final monograph … Therefore, under the Regulatory Flexibility Act, no further analysis is required.
60 FR 10286Health and Human Services DepartmentFood and Drug AdministrationFederal Register · Notice · Apr 24, 2009
Addresses : Electronic comments should be submitted to http://www.regulations.gov . … All comments received will be posted without change, including any personal information provided.
74 FR 18731Health and Human Services DepartmentFood and Drug Administration
Ask Donna what matters in the record.
She can read the source against your case and show you exactly where the answer came from.